Dibasic Calcium Phosphate
31 Inquiries
7757-93-9
Pharmaceutical Grade
Any China Port
25 kgs/drum
2024-12-05
API,Intermediate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Calcium phosphate dibasic
Other Name:calciumdibasicphosphate;calciumperphosphate,ammonified,granular;calciumphosphate(1:1);CALCIUM ORTHOPHOSPHATE;CALCIUM MONOHYDROGEN PHOSPHATE;CALCIUM MONOHYDROGEN PHOSPHATE, DIBASIC;CALCIUM PHOSPHATE, DIBASIC;CALCIUM HYDROGEN ORTHOPHOSPHATE
CAS No.:7757-93-9
Molecular Formula:CaHO4P
InChIKeys:FUFJGUQYACFECW-UHFFFAOYSA-L
Molecular Weight:136.06
Exact Mass:135.923843
EC Number:231-826-1
UNII:L11K75P92J
TSCA:TSCA listed
DSSTox ID:DTXSID20872529
Color/Form:White
HScode:2835 25 00
Categories:
Characteristics-
PSA:
83.4
Physical Properties:White triclinic crystal; density 2.92 g/cm3(anhydrous) and 2.31 g/cm3(dihy drate); hardness 3.5 Mohs; decomposes on heating; inosluble in water and alcohol; KSP 2.7x10-7; soluble in dilute mineral acid.
XLogP3:-0.05220
Appearance:DryPowder; DryPowder, PelletsLargeCrystals; OtherSolid; PelletsLargeCrystals
Density:2.306(16℃)
Melting Point:370°C(decomposition)
Boiling Point:158ºC at 760 mmHg
Refractive Index:Index of refraction = 1.5576, 1.5457, 1.5392 /Calcium hydrogen phosphate dihydrate/
Water Solubility:Sparingly soluble in water, practically insoluble in cold water.
Storage Conditions:2-8°C
Toxicity:LD50 orally in Rabbit: 10000 mg/kg LD50 dermal Rabbit > 7940 mg/kg
Flammability characteristics:Non flammable
Odor:Odorless
Taste:Tasteless
PH:7 (10g/l, H2O, 20°C) suspension
Experimental Properties:At red heat dehydrated to calcium pyrophosphate|Loses water @ 109 °C /hydrate/|Slowly converted to the anhydrous salt at 36 °C. Dissolves in water with precipitation of the hydroxyapitite, Ca5(PO4)3OH, and formation of an aqueous phase with increasing P2O5 content. /Dihydrate/
Critical Temperature & Pressure:2-8°C
Hazard IdentificationClassification of the substance or mixture
Not classified.
GHS label elements, including precautionary statements
Pictogram(s) No symbol. Signal word No signal word
Hazard statement(s) none
Precautionary statement(s) Prevention none
Response none
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.

Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.

Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Inquiry History31 Inquiries
Country Product Purchase Quantity Date Posted
Pakistan
Di calcium phosphate
1 20' Fcl Jul 16, 2026
Bangladesh
DCP Powder
25 KG May 6, 2026
Pakistan
Dicalcium Phosphate Anhydrous
600 MT Mar 29, 2026
Pakistan
Dicalcium phosphate
1.00 KG Sep 20, 2025
India
Dicalcium Phosphate
25000.00 KG Aug 14, 2025
India
Calcium hydrogenphosphate
2000 MT Jan 23, 2025
India
Dicalcium Phosphate
5000.00 KG Dec 25, 2024
India
Dicalcium phosphate
400.00 TON Dec 23, 2024
Spain
Calcium Hydrogen phospate anhydrous
1000 KG Dec 2, 2024
India
Dicalcium phosphate
600.00 MT Nov 30, 2024
India
Dicalcium Phosphate (DCP)
1.00 MT Jul 29, 2024
India
Dicalcium phosphate
30.00 TON Jul 29, 2024
Egypt
dibasic calcium phosphate
1 20' Fcl Feb 26, 2024
United Kingdom
Dicalcium phosphate anhydrous 20% P content (DCPA 20)
72 MT Sep 15, 2023
Malaysia
DCP
2 20' Fcl Aug 29, 2023
India
Dic calcium phosphate
300 MT Jul 22, 2026
Bangladesh
Calcium hydrogen phosphate
8 MT Dec 11, 2025
India
Calcium hydrogenphosphate
50 MT Sep 11, 2025
India
Dicalcium phosphate
100.00 MT Jul 1, 2025
Pakistan
DCP
1000 KG May 14, 2025 Post an enquiry for this product